Global Defibrillator Market

Global Defibrillator Market Size, Share, Growth Analysis, By Product(Implantable Cardioverter Defibrillators (ICD), and External Defibrillators (ED)), By End-User(Hospital, Pre-Hospital) - Industry Forecast 2024-2031


Report ID: SQMIG35A2240 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 64 | Figures: 75

Global Defibrillator Market Regional Insights

In 2022, North America had the highest revenue contribution of more than 35.0%. The expansion of the North American market may be ascribed to key companies' endeavors, favorable legislation, and highly technological medical centers in the United States and Canada. There were 16,500 registered in the United States alone, indicating a high rate of adoption.

Asia Pacific is predicted to expand at the fastest CAGR of 8.1% during the forecast period. This is because of the expanding healthcare infrastructure, the big patient population, and the frequency of heart problems. Because of high defibrillator adoption and supportive policies, the Japanese market is accelerating regional expansion. In fact, the Japanese industry leader Nihon Kohden sold over USD 66,000 mechanical exterior defibrillators.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Defibrillator Market size was valued at USD 12.76 Billion in 2022 and is poised to grow from USD 13.68 Billion in 2023 to USD 23.86 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

The market is characterized by fierce competition. Market participants use a variety of strategic strategies to improve their market share. Creation of products, regional expansion, collaborations and partnerships, and mergers and acquisitions are examples of these. 'Medtronic plc', 'Philips Healthcare', 'Abbott Laboratories', 'Boston Scientific Corporation', 'ZOLL Medical Corporation', 'Physio-Control, Inc. (a Stryker Company)', 'Cardiac Science Corporation', 'Nihon Kohden Corporation', 'Koninklijke Philips NV.', 'SCHILLER AG', 'CU Medical Systems, Inc.', 'Progetti S.r.l.', 'Mindray Medical International Limited', 'Defibtech, LLC', 'LivaNova PLC', 'Cardionet, LLC (a BioTelemetry Company)', 'Biotronik SE & Co. KG', 'Welch Allyn (a Hill Rom Company)', 'Cardiac Science Corporation', 'Physio-Control, Inc. (a Stryker Company)'

Technological Advancements: The defibrillator market is witnessing rapid technological advancements aimed at enhancing device performance, ease of use, and patient outcomes. Key technological trends include the integration of artificial intelligence (AI) algorithms for more accurate detection of cardiac rhythms, wireless connectivity for remote monitoring and data transmission, and improved user interfaces for intuitive operation.

In 2022, North America had the highest revenue contribution of more than 35.0%. The expansion of the North American market may be ascribed to key companies' endeavors, favorable legislation, and highly technological medical centers in the United States and Canada. There were 16,500 registered in the United States alone, indicating a high rate of adoption.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Defibrillator Market

Product ID: SQMIG35A2240

$5,300
BUY NOW GET FREE SAMPLE